36. Johnson & Johnson 2013 ($2,269 million)
Johnson & Johnson and two subsidiaries settled a raft of claims from federal and state agencies in November 2013, following allegations of off-label marketing and kickback payments to doctors.
To read more
Subscribe to Global Investigations Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Investigations Review experts.
Subscribe now